With Allergan megamerger looming, AbbVie plots massive $28B bond offering: Bloomberg

Megamergers are reshaping the drug industry, and now AbbVie—which inked a massive Allergan buyout earlier this year—is set to embark on a hefty bond offering as it seeks to close its deal, Bloomberg reports.